Export

EN
FR
Infliximab
Essential medicine status
General description

INN
Infliximab
Medicine type
Biological agent
EML status history
First added in 2023 (TRS 1049) for Rheumatoid arthritis
Changed in 2023 (TRS 1049) for Axial spondyloarthritis
Changed in 2023 (TRS 1049) for Crohn disease site
Therapeutic equivalent for
adalimumab for Axial spondyloarthritis, unspecified
adalimumab for Crohn disease, unspecified site
adalimumab for Juvenile idiopathic arthritis, unspecified
adalimumab for Rheumatoid arthritis
Wikipedia
Infliximab
DrugBank
Infliximab